TR199700020T1 - Selüler yapisma inhibitörü olarak (-)-(3R)-3-metil-4-£4-£4-(4-piridil) piperazin-1-il-|fenoksi|bütirik asit. - Google Patents

Selüler yapisma inhibitörü olarak (-)-(3R)-3-metil-4-£4-£4-(4-piridil) piperazin-1-il-|fenoksi|bütirik asit.

Info

Publication number
TR199700020T1
TR199700020T1 TR97/00020T TR9700020T TR199700020T1 TR 199700020 T1 TR199700020 T1 TR 199700020T1 TR 97/00020 T TR97/00020 T TR 97/00020T TR 9700020 T TR9700020 T TR 9700020T TR 199700020 T1 TR199700020 T1 TR 199700020T1
Authority
TR
Turkey
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
TR97/00020T
Other languages
English (en)
Turkish (tr)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of TR199700020T1 publication Critical patent/TR199700020T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
TR97/00020T 1995-06-01 1996-05-28 Selüler yapisma inhibitörü olarak (-)-(3R)-3-metil-4-£4-£4-(4-piridil) piperazin-1-il-|fenoksi|bütirik asit. TR199700020T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
TR199700020T1 true TR199700020T1 (tr) 1997-04-22

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00020T TR199700020T1 (tr) 1995-06-01 1996-05-28 Selüler yapisma inhibitörü olarak (-)-(3R)-3-metil-4-£4-£4-(4-piridil) piperazin-1-il-|fenoksi|bütirik asit.

Country Status (31)

Country Link
EP (1) EP0796247A1 (sk)
JP (1) JP2885941B2 (sk)
KR (1) KR100245957B1 (sk)
AT (1) AT406675B (sk)
AU (1) AU710105B2 (sk)
BE (1) BE1009520A5 (sk)
BR (1) BR9606409A (sk)
CA (1) CA2194397A1 (sk)
CH (1) CH691808A5 (sk)
CZ (1) CZ26997A3 (sk)
DE (1) DE19680509T1 (sk)
DK (1) DK10697A (sk)
ES (1) ES2137886B1 (sk)
FI (1) FI970393A (sk)
GB (1) GB2304340B (sk)
GR (1) GR1002702B (sk)
HU (1) HUP9700274A3 (sk)
IE (1) IE960405A1 (sk)
IL (1) IL118477A0 (sk)
IT (1) IT1290839B1 (sk)
LU (1) LU90008B1 (sk)
MC (1) MC2418A1 (sk)
MX (1) MX9700379A (sk)
NL (1) NL1003243C2 (sk)
NO (1) NO307460B1 (sk)
NZ (1) NZ308597A (sk)
PL (1) PL318440A1 (sk)
SE (1) SE510812C2 (sk)
SK (1) SK13097A3 (sk)
TR (1) TR199700020T1 (sk)
WO (1) WO1996038416A1 (sk)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
DK0691959T3 (da) * 1993-03-29 1999-04-26 Zeneca Ltd Heterocykliske derivater som blodpladeaggregations-inhibitorer

Also Published As

Publication number Publication date
AU710105B2 (en) 1999-09-16
ES2137886B1 (es) 2000-08-16
NL1003243C2 (nl) 1996-12-04
FI970393A0 (fi) 1997-01-30
ES2137886A1 (es) 1999-12-16
NZ308597A (en) 1998-11-25
HU9700274D0 (en) 1997-04-28
BE1009520A5 (fr) 1997-04-01
CH691808A5 (de) 2001-10-31
MX9700379A (es) 1997-04-30
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
SE9700203L (sv) 1997-01-24
ATA900596A (de) 1999-12-15
KR100245957B1 (ko) 2000-04-01
NO970437D0 (no) 1997-01-31
HUP9700274A3 (en) 2000-02-28
IT1290839B1 (it) 1998-12-14
GB2304340B (en) 1998-07-29
CZ26997A3 (en) 1997-08-13
GB9627127D0 (en) 1997-02-19
BR9606409A (pt) 1997-09-30
SK13097A3 (en) 1997-08-06
AU5827296A (en) 1996-12-18
NO970437L (no) 1997-02-20
HUP9700274A2 (hu) 1999-06-28
IE960405A1 (en) 1996-12-11
IL118477A0 (en) 1996-09-12
JP2885941B2 (ja) 1999-04-26
ITMI961113A1 (it) 1997-12-01
JPH09512836A (ja) 1997-12-22
PL318440A1 (en) 1997-06-09
GB2304340A (en) 1997-03-19
MC2418A1 (fr) 1997-05-23
GR1002702B (el) 1997-05-22
DK10697A (da) 1997-04-01
DE19680509T1 (de) 1997-12-04
SE9700203D0 (sv) 1997-01-24
CA2194397A1 (en) 1996-12-05
NO307460B1 (no) 2000-04-10
WO1996038416A1 (en) 1996-12-05
SE510812C2 (sv) 1999-06-28
LU90008B1 (fr) 1997-04-16
FI970393A (fi) 1997-01-30
ITMI961113A0 (it) 1996-05-31
KR970704689A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
DE19680255T1 (de) Inhibitoren der Enzymaktivität von Rotamase
NO974213L (no) Små-molekylære inhibitorer for rotamase-enzym-aktivitet
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
TR199501472A2 (tr) Matriks metaloproteaz inhibitörler.
NO981938D0 (no) Proteaseinhibitorer
DE69522690T2 (de) alpha-ketogultarsäure dehydrogenasegen
DK0925303T3 (da) Phosphinsyreamider som matrixmetalloproteaseinhibitorer
NO993587D0 (no) Sulfonamid-metalloprotease-inhibitorer
DK1023268T3 (da) Isoquinoliner som urokinaseinhibitorer.
TR28254A (tr) Alfa-pirimidinil akrilik asit türevleri.
NO991994D0 (no) Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriks-metalloproteaseinhibitorer
EE9800044A (et) Prolüülendopeptidaasi inhibiitorid
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
TR199700020T1 (tr) Selüler yapisma inhibitörü olarak (-)-(3R)-3-metil-4-£4-£4-(4-piridil) piperazin-1-il-|fenoksi|bütirik asit.
TR199600772A2 (tr) 2-(4-Pirazoliloksi-Pirimidin-5-il) asetik asit türevleri.
TR199600607A2 (tr) Insektisidlerin iticiligini azaltmaya mahsus para-hidroksifenilasetik asit.
TR27776A (tr) 2-oksimino-2-tiyenil-asetik asit türevleri.
IT239603Y1 (it) Struttura di calzatura, particolarmente per pattini
NO965353D0 (no) 3-amino-2-okso-1-piperidineddiksyrederivater som enzyminhibitorer
ITRM960100V0 (it) Pellicola effetto antico craquelures per contatto.
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
ID18481A (id) 2-(3,5-difluorofenil)-3-(4-metilsulfonil)fenil)-2-siklopenten-1-on yang berguna sebagai inhibitor cox-2
KR970000223A (ko) 콜레스테롤 생합성 저해제
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
IT1275260B (it) Chiodo particolarmente per calzature